CD40L Antagonism in Rheumatoid Arthritis (RA)
Clinical trial NCT05306353 · TERMINATED
Trial details
- NCT number
- NCT05306353
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-25
- Primary completion
- 2025-07-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.